Gastroparesis Awareness Month 2026: Turn Awareness into an Accountable Care Route

Make an invisible pathway failure visible to leadership

Gastroparesis Awareness Month gives hospital and health-system leaders a focused opportunity to examine what happens when persistent symptoms meet a fragmented care system. The executive issue is larger than awareness of a digestive disorder. It is whether the organization can recognize a complex presentation, complete an appropriate diagnostic route, identify nutrition and medication risks, coordinate care across settings, and close the loop with the patient.

Gastroparesis is defined by symptoms and objectively delayed gastric emptying in the absence of mechanical obstruction. Symptoms alone do not establish the diagnosis. They can overlap with other upper gastrointestinal conditions, which makes disciplined evaluation and standardized testing especially important. Current reviews and guidance place objective assessment, nutrition support, medication review, and patient-specific treatment decisions within the same care continuum. [1], [18]

That continuum often crosses primary care, gastroenterology, endocrinology, emergency medicine, hospital medicine, nursing, pharmacy, dietetics, behavioral health, dentistry, diagnostic imaging, surgery, and scheduling. When each group manages only its own encounter, a patient may receive repeated work without a completed route. When the system assigns ownership across the full journey, the same observance can become a practical test of access, coordination, trust, and accountability.

The boardroom question is therefore straightforward: Can the health system show that a person who enters with persistent symptoms reaches a defined next step, receives a communicated result and plan, and has a named owner for follow-through?

This observance gives healthcare executives an opportunity to reduce diagnostic delay, prevent avoidable nutrition and medication harm, and improve continuity by building one accountable gastroparesis pathway across ambulatory, emergency, inpatient, and specialty care.

This article offers organizational guidance for healthcare leaders. It does not provide individual medical advice, recommend a specific treatment, or replace patient-specific judgment by qualified clinicians.

Make diagnostic standardization an operating system

The diagnostic challenge begins with overlap. In a tertiary-center study of adults with upper gastrointestinal symptoms, delayed gastric emptying was present in only a subset of people with gastroparesis-like symptoms. The study excluded diabetes and prior abdominal surgery and used a center-specific threshold, so its findings should not be generalized to every population. Its central operational lesson remains useful: symptoms may trigger evaluation, but they should not become a diagnosis by default. [14]

Primary-care registry data provide a second signal. A large Belgian study found differences between coded diagnoses in primary care and estimates derived through other approaches. Because the study combined functional dyspepsia and gastroparesis codes and could not capture people who never sought care, it does not provide a transferable US prevalence estimate. It does, however, support an audit question: Where between first presentation, referral, testing, and result communication does the route stop? [12]

A standardized system does not mean forcing every patient through an identical sequence. It means defining the decision points, minimum documentation, accountable owner, and acceptable variation. The current review and guideline support a pathway in which clinicians assess symptoms and differential diagnoses, exclude mechanical obstruction, use objective gastric-emptying testing when appropriate, and integrate results into a patient-specific plan. Four-hour gastric-emptying scintigraphy is described as the criterion-standard route in current guidance, while local protocols still need qualified oversight, consistent preparation, and clear interpretation. [1], [18]

Leaders should ask the medical staff and operational teams to specify the complete route:

• Which symptom patterns or clinical concerns prompt further evaluation?
• Who reconciles medications that may affect gastric emptying or test interpretation?
• How is obstruction excluded, and how is that step documented?
• Which testing protocol is used, who maintains it, and how are preparation instructions made accessible?
• What happens when a scheduled test is not completed?
• Who communicates the result, explains what it does and does not show, and assigns the next step?
• How are patients with severe nutrition, hydration, glycemic, or acute-care concerns escalated while evaluation continues?

The route should be visible in order entry, referral guidance, scheduling workflows, patient instructions, and result queues. Standardization fails if it exists only in a committee document. A patient-facing instruction that is hard to understand, inaccessible to a person with a disability, unavailable in the needed language, or disconnected from transportation realities can undermine an otherwise sound test protocol.

Closed-loop management is as important as test completion. A completed study without documented interpretation, result communication, and next-step ownership is not a completed diagnostic route. The system should be able to identify ordered tests that were never scheduled, scheduled tests that were not completed, completed tests without communicated results, and results without a documented plan.

The organization also needs a route for uncertainty. A negative or inconclusive result does not mean a patient's symptoms are unimportant, and it should not end communication. Because gastroparesis-like symptoms overlap with other conditions, the pathway should return the patient to an accountable clinician who can explain the result and guide the next appropriate evaluation. [14], [18] This is both a clinical and trust standard.

Build nutrition, hydration, glycemic, and medication safety into the first response

Nutrition risk should not wait until a procedure is being considered. Gastroparesis can affect food tolerance, hydration, weight, glucose management, and the ability to follow a usual medication routine. The 2026 scoping review and 2022 systematic review both show that dietary evidence is limited, heterogeneous, and not sufficient to justify one public meal plan for everyone. [2], [16] The executive response is not a generic handout. It is timely access to assessment, clear escalation criteria, and follow-up that can detect worsening risk.

An effective first response can include a defined nutrition-risk screen, hydration review, weight history, relevant laboratory or clinical assessment as determined by clinicians, and referral criteria for a registered dietitian with suitable expertise. The system should state who acts on the screen and within what interval. It should also define how urgent needs reach the appropriate clinician when routine specialty capacity is constrained.

Severe refractory disease illustrates why early detection matters. A retrospective surgical-practice review described patients who received jejunostomy tubes for severe malnutrition and followed oral-intake outcomes over one year. This was a highly selected population treated across a long period, without randomized comparison. It cannot determine what an individual patient should receive. [8] It can, however, remind leaders that unresolved nutrition failure may lead to prolonged, complex care. A pathway should identify deterioration before the only visible option is an emergency encounter or procedural escalation.

Nutrition governance also needs safeguards against unintended harm. Restrictive eating advice can create confusion, cost, and social burden, particularly when the evidence does not support a universal approach. The 2026 review found that included studies rarely assessed diet-related quality of life and did not examine disordered eating. [2] That gap supports screening and referral practices that distinguish symptom-driven restriction, nutrition risk, and other concerns without making assumptions about a patient's behavior or intent. The related organizational lesson is to coordinate digestive-health and eating-disorder expertise when the presentation warrants it.

Hydration and glycemic concerns need explicit ownership. For patients with diabetes, gastric emptying, food intake, glucose patterns, and medication management can interact. A 2025 prospective study in one Cairo university diabetes clinic used symptom screening, scintigraphy, and short follow-up in a small cohort. Its size and setting limit transferability, but it demonstrates the value of defining what a symptom screen triggers and how an objective result returns to the diabetes-care plan. [7] Endocrinology and gastroenterology should not operate as separate endpoints when the patient needs one coordinated route.

Medication reconciliation should be built into each relevant transition: referral, diagnostic preparation, emergency or inpatient admission, discharge, and specialty follow-up. Current review and guideline sources describe medication considerations as part of diagnosis and management. [1], [18] The large 2026 observational study of glucagon-like peptide-1 receptor agonists adds a contemporary safety signal but cannot prove individual causation. [3] The operational standard should therefore be a documented, clinician-led review with a clear escalation channel. Public materials should never tell readers to stop, delay, or change a medicine on their own.

Oral health is another often-unseen need. A survey of 434 participants recruited through a gastroparesis social-media forum reported oral-health symptoms, care use, and education gaps. Self-report, convenience recruitment, and the lack of clinical dental examinations limit the findings. [11] Even with those limits, the study supports a simple pathway question: When repeated vomiting, dietary restriction, dryness, or other concerns raise an oral-health issue, can the patient receive education and an appropriate dental referral?

For leadership, the first-response bundle is not a treatment protocol. It is a reliability standard. Each qualifying encounter should make nutrition, hydration, glycemic, medication, and oral-health needs visible to the right professional, with escalation based on patient-specific assessment.

Build multidisciplinary care around the patient

Gastroparesis exposes the cost of specialty silos. A patient may need primary-care recognition, gastroenterology evaluation, diagnostic testing, diabetes management, nutrition support, pharmacy review, acute-care treatment, behavioral-health support, dental care, or procedural consultation. A clinical overview and current guidance both describe care that spans these functions. [10], [18] The executive task is to turn a list of disciplines into a coordinated service.

Coordination starts with role clarity. Primary care may recognize persistent symptoms and maintain continuity. Gastroenterology may lead diagnostic evaluation and selected treatment decisions. Nuclear medicine or another diagnostic service may own test protocol and quality. Nursing may provide education, symptom assessment, and navigation. Pharmacy may review medication exposure, interactions, formulation concerns, and safe escalation to prescribers. Dietetics may assess nutrition risk and help shape an individualized plan. Endocrinology may coordinate diabetes management. Behavioral health can address distress without recasting physical symptoms as psychological. Dentistry can respond to oral-health needs. Emergency and hospital teams can stabilize acute concerns and connect the patient back to longitudinal care.

No role list is complete without a named coordinator. The coordinator does not need to make every clinical decision. The role needs authority to see the route, identify an incomplete handoff, contact the responsible team, and tell the patient what happens next. Depending on local resources, the work may sit with an ambulatory nurse, referral coordinator, navigator, advanced-practice clinician, or team-based inbox. The title matters less than the accountability.

Leaders should protect capacity for this work. Navigation cannot be treated as invisible labor added to an already full clinical day. The pathway needs staffing assumptions, coverage during absence, response-time expectations, and escalation rules. It also needs interoperability across scheduling, referrals, diagnostic results, pharmacy information, discharge workflows, and patient messaging.

Multidisciplinary review should be proportionate. Not every case requires a conference. A defined trigger can route unresolved, high-risk, or refractory cases to a coordinated review. The goal is to prevent sequential, disconnected referrals in which each service restarts the history and no one integrates the decisions. For selected refractory care, observational studies of procedures show why outcomes should be reviewed across symptom, nutrition, glycemic, emergency-use, and hospitalization domains rather than through one measure alone. [4], [8] Those studies do not establish universal treatment effects. They support broader follow-through.

Treat emergency and hospital use as a pathway signal

Emergency departments and inpatient units will continue to care for people with acute symptoms, dehydration, glycemic concerns, pain, vomiting, or other needs that require prompt assessment. The executive opportunity is not to label those encounters as inappropriate. It is to learn whether the longitudinal pathway failed before arrival and whether discharge returns the patient to accountable care.

National inpatient analyses show that gastroparesis hospitalizations span age groups and differ across demographic and clinical categories. Admission-level administrative data cannot measure community prevalence, access before admission, or causal pathways. [17] These data should prompt stratified local review rather than an average-patient model.

Another national inpatient analysis found that hospitalizations with documented mood disorders were associated with greater complexity and longer stays. Administrative codes cannot establish whether psychiatric factors caused symptoms or resource use, and the study does not justify attributing physical symptoms to mental health conditions. [9] The proper response is respectful psychosocial assessment and coordinated support, not diagnostic dismissal.

An acute-care pathway should help emergency and hospital teams see relevant prior testing, recent medication review, nutrition concerns, and the accountable outpatient team. It should reduce repeated history taking and duplicative work when safe, while preserving clinician judgment for a new or changed presentation. Standardized discharge elements can include a reconciled medication list, a documented nutrition or hydration concern when present, a named follow-up service, an appointment or outreach task when possible, and clear patient-specific return instructions from the treating team.

Hospitals should review repeat use as a learning signal. A case review can ask whether the patient lacked access to specialty care, could not complete testing, did not receive a result, could not obtain a prescribed therapy, experienced an unclear transition, or faced transportation, communication, or benefit barriers. These questions are more useful than assuming a motivation for the encounter.

For selected patients with refractory disease, observational procedural studies report outcomes across longer follow-up periods. A 2026 multicenter electronic-health-record cohort examined surgical therapy among adults with concurrent diabetes and gastroparesis, using propensity matching but retaining the limits of nonrandomized treatment selection. [4] A separate study described jejunostomy outcomes in a highly selected population with severe malnutrition. [8] These sources support careful multidisciplinary review and domain-based follow-up. They do not support a universal procedural pathway.

The acute-care scorecard should connect to the ambulatory scorecard. Emergency and inpatient teams can report whether follow-up was assigned and completed, while ambulatory teams can report whether post-discharge contact resolved the intended handoff. The shared measure is continuity, not ownership of a single encounter.

Measure the patient experience beyond a symptom score

Patient experience is not a soft companion to clinical performance. It is information about whether the service works. Gastroparesis may affect eating, hydration, sleep, work, school, caregiving, social participation, and the ability to plan a day. A 2026 online study described associations among gastrointestinal symptoms, fatigue, cognitive complaints, distress, and quality of life. Its self-selected, predominantly female sample and cross-sectional design prevent causal or population-wide claims. [5] The finding still supports a broader assessment of function.

Oral-health survey findings and stigma interviews reinforce the same point. [11], [19] If the service measures only a diagnostic test and encounter volume, it may miss dental concerns, participation limits, emotional burden, or communication harms that influence whether the patient can use the care plan.

Executives can ask teams to choose a concise, validated patient-reported approach appropriate to their setting and population. The measurement set might include symptoms, daily function, fatigue, confidence in the plan, communication, and care burden. It should be short enough to use and linked to a response. Collecting distress or nutrition-risk information without a defined escalation pathway can create a new form of nonresponse.

The organization should separate patient-reported outcomes from patient-reported experience. Outcomes describe health status or function. Experience describes how care was delivered, including access, respect, clarity, coordination, and trust. Both matter, but they answer different questions. Neither should be substituted for objective diagnostic standards.

Measurement should also recognize the limits of averages. A stable system mean can conceal a subgroup with long waits, repeated acute-care use, or poor result closure. Stratification and narrative review help leaders see where the pathway works unevenly. Patient stories can illustrate the nature of a failure, but they should not be presented as invented testimonials or as proof of population frequency.

Build a decision-grade scorecard

Campaign reach is not a care outcome. Website views, social impressions, event attendance, and referral volume can describe attention, but they do not show whether people reached diagnosis, received support, or completed follow-up. A decision-grade scorecard should connect awareness to pathway reliability.

Leaders can organize measures across eight domains:

Each measure needs a precise definition, data source, accountable owner, review cadence, and escalation threshold. The organization should establish a baseline before setting improvement targets. It should also record exclusions, missing data, and patient choice so that the dashboard does not reward superficial closure.

The scorecard should distinguish reach, access, reliability, resolution, experience, and equity:

• Reach asks whether intended audiences received understandable information.
• Access asks whether patients entered the appropriate pathway.
• Reliability asks whether required steps occurred as designed.
• Resolution asks whether the result and next step were completed, not merely ordered.
• Experience asks whether care was respectful, clear, and usable.
• Equity asks whether performance differs across groups or access conditions.

Resource-use studies help explain why continuity belongs on the dashboard. Claims and health-system analyses associate gastroparesis with sustained service use, but they cannot reveal the appropriateness or quality of each encounter. [13], [15] The right response is not a blunt utilization-reduction target. It is to identify open loops, improve ambulatory access, and review repeat use alongside patient safety and experience.

Hospitalization data should be stratified rather than pooled into a single average. [17] Procedure-selection data should prompt review of referral, authorization, geography, and selection processes, without declaring inequity from administrative associations alone. [20] Patient-reported measures should be interpreted within the limits of their samples. [5], [11], [19] These guardrails make the scorecard more trustworthy.

Boards do not need every operational detail. They do need a clear account of whether the pathway is defined, whether open loops are declining, whether high-risk needs are acted on, whether differences across groups are understood, and whether capacity matches public commitments. A quarterly board or quality-committee view can summarize these domains while clinical and operational teams review process detail more often.

Connect public communication to a real destination

Gastroparesis Awareness Month communication should tell the truth about both the condition and the health system's response. Public messages can acknowledge that symptoms may be burdensome and that diagnosis requires appropriate evaluation. They should avoid presenting symptoms alone as proof of gastroparesis, promoting one diet as universally effective, directing medication changes, or implying that one procedure is right for everyone. [1], [2], [3], [16], [18]

Every call to action needs a usable destination. If the message says “talk with your care team,” the organization should ensure that primary-care and ambulatory staff know how to route the question. If it invites referrals, the referral pathway should have criteria, capacity, and status communication. If it names nutrition support, leaders should confirm that the service exists and can accept demand. If it mentions research, it should distinguish eligibility screening from enrollment and enrollment from benefit. [6]

Communication should be available in relevant languages and accessible formats. It should use person-centered wording, describe uncertainty without dismissal, and avoid dramatic imagery that turns illness into spectacle. Generated editorial images should be labeled as illustrative and should not be presented as patients, employees, research participants, or proof of outcomes.

The strongest awareness message is an operating promise the organization can keep: We will listen, follow a defined route, explain results, address safety concerns, and tell you who owns the next step.

The leadership standard after August

Gastroparesis Awareness Month should leave behind more than education. It should leave a stronger care system for people whose symptoms can be difficult to name, diagnose, and manage across settings.

The executive standard is not certainty in every case. It is disciplined follow-through despite uncertainty. Symptoms are heard without becoming an automatic diagnosis. Objective testing is standardized and completed when appropriate. Nutrition, hydration, glycemic, medication, oral-health, and psychosocial needs reach qualified review. Acute-care encounters connect back to longitudinal care. Patient experience and equity inform decisions. Results are communicated, and every next step has an owner.

Research limitations should sharpen this work, not weaken it. Dietary studies remain small and heterogeneous. Several utilization and procedure studies are observational. Patient-experience studies use limited samples. Registry and administrative data cannot explain every pathway. [2], [4], [5], [6], [8], [11], [13], [15], [16], [17], [19], [20] These limits call for honest public language, careful local measurement, and learning that does not overstate causation.

For the CEO, COO, CMO, CNO, CFO, and board, the shared question is whether organizational promises match operating capacity. For clinical and operational teams, the question is whether the patient can see the route and complete it. For patients and caregivers, the question is simpler: Will someone listen, explain what comes next, and stay accountable until the handoff is closed?

That is the year-round work behind this observance.